;PMID: 12871580
;source_file_2883.mrg
;Release 0.9 of PennBioIE
;Funded by NSF ITR EIA-0205448

;0)section:[e:0..37] = [t:0..37]
;1)sentence:[e:43..150] = [t:43..150]
;2)section:[e:154..219] = [t:154..219]
;3)section:[e:223..324] = [t:223..324]
;4)sentence:[e:328..455] = [t:328..455]
;5)sentence:[e:456..510] = [t:456..510]
;6)sentence:[e:511..645] = [t:511..645]
;7)sentence:[e:646..759] = [t:646..759]
;8)sentence:[e:760..993] = [t:760..993]
;9)sentence:[e:994..1070] = [t:994..1070]
;10)sentence:[e:1071..1212] = [t:1071..1212]
;11)sentence:[e:1213..1367] = [t:1213..1367]
;12)section:[e:1371..1416] = [t:1371..1416]

;section 0 Span:0..37
;J Neurochem.  2003 Jul;86(2):394-404.
(SEC
  (FRAG (NNP:[0..1] J) (NNP:[2..11] Neurochem) (.:[11..12] .) ('':[14..18] 2003)
        (NNP:[19..24] Jul;8) (CD:[24..26] 6-LRB-) (CD:[26..27] 2)
        (-RRB-:[27..28] -RRB-) (::[28..29] :) (CD:[29..32] 394)
        (CD:[32..36] -404) (.:[36..37] .)))

;sentence 1 Span:43..150
;Alzheimer's associated variant ubiquitin causes inhibition of the 26S
;proteasome  and chaperone expression.
;[74..83]:gene-protein:"ubiquitin"
;[109..123]:gene-protein:"26S proteasome"
;[129..138]:gene-protein:"chaperone"
(SENT
  (S
    (NP-SBJ
      (NML
        (NML
          (NP (NNP:[43..52] Alzheimer) (POS:[52..54] 's))
          (ADJP (VBN:[55..65] associated)))
        (JJ:[66..73] variant))
      (NN:[74..83] ubiquitin))
    (VP (VBZ:[84..90] causes)
      (NP
        (NP (NN:[91..101] inhibition))
        (PP (IN:[102..104] of)
          (NP (DT:[105..108] the)
            (NML
              (NML
                (NML (NN:[109..112] 26S) (NN:[113..123] proteasome))
                (NML-1 (-NONE-:[123..123] *P*)))
              (CC:[125..128] and)
              (NML (NN:[129..138] chaperone)
                (NML-1 (NN:[139..149] expression))))))))
    (.:[149..150] .)))

;section 2 Span:154..219
;Hope AD, de Silva R, Fischer DF, Hol EM, van Leeuwen FW, Lees AJ.
(SEC
  (FRAG (NNP:[154..158] Hope) (NNP:[159..161] AD) (,:[161..162] ,)
        (NNP:[163..165] de) (NNP:[166..171] Silva) (NNP:[172..173] R)
        (,:[173..174] ,) (NNP:[175..182] Fischer) (NNP:[183..185] DF)
        (,:[185..186] ,) (NNP:[187..190] Hol) (NNP:[191..193] EM)
        (,:[193..194] ,) (NNP:[195..198] van) (NNP:[199..206] Leeuwen)
        (NNP:[207..209] FW) (,:[209..210] ,) (NNP:[211..215] Lees)
        (NNP:[216..219] AJ.)))

;section 3 Span:223..324
;Reta Lila Weston Institute of Neurological Studies, University College,
;London,  UK. a.hope@ucl.ac.uk
(SEC
  (FRAG (NNP:[223..227] Reta) (NNP:[228..232] Lila) (NNP:[233..239] Weston)
        (NNP:[240..249] Institute) (IN:[250..252] of)
        (NNP:[253..265] Neurological) (NNS:[266..273] Studies) (,:[273..274] ,)
        (NNP:[275..285] University) (NNP:[286..293] College) (,:[293..294] ,)
        (NNP:[295..301] London) (,:[301..302] ,) (NNP:[304..307] UK.)
        (DT:[308..309] a) (NN:[309..318] .hope@ucl) (.:[318..324] .ac.uk)))

;sentence 4 Span:328..455
;Intracellular protein inclusions in Alzheimer's disease and progressive 
;supranuclear palsy contain UBB+1, a variant ubiquitin.
;[428..433]:gene-protein:"UBB+1"
;[445..454]:gene-protein:"ubiquitin"
(SENT
  (S
    (NP-SBJ
      (NP
        (NP (JJ:[328..341] Intracellular) (NN:[342..349] protein)
            (NNS:[350..360] inclusions))
        (PP (IN:[361..363] in)
          (NP
            (NP (NNP:[364..373] Alzheimer) (POS:[373..375] 's))
            (NN:[376..383] disease))))
      (CC:[384..387] and)
      (NP (JJ:[388..399] progressive) (JJ:[401..413] supranuclear)
          (NN:[414..419] palsy)))
    (VP (VBP:[420..427] contain)
      (NP
        (NP (NN:[428..433] UBB+1))
        (,:[433..434] ,)
        (NP (DT:[435..436] a) (JJ:[437..444] variant) (NN:[445..454] ubiquitin))))
    (.:[454..455] .)))

;sentence 5 Span:456..510
;UBB+1 is able block the  26S proteasome in cell lines.
;[456..461]:gene-protein:"UBB+1"
;[481..495]:gene-protein:"26S proteasome"
(SENT
  (S
    (NP-SBJ (NN:[456..461] UBB+1))
    (VP (VBZ:[462..464] is)
      (ADJP-PRD (JJ:[465..469] able)
        (S
          (NP-SBJ (-NONE-:[469..469] *))
          (VP (VB:[470..475] block)
            (NP (DT:[476..479] the)
               (NN:[481..484] 26S) (NN:[485..495] proteasome))
            (PP (IN:[496..498] in)
              (NP (NN:[499..503] cell) (NNS:[504..509] lines)))))))
    (.:[509..510] .)))

;sentence 6 Span:511..645
;Proteasome inhibition by drug action has  previously been shown to induce a
;heat-shock response and render protection  against stress.
;[511..521]:gene-protein:"Proteasome"
(SENT
  (S
    (NP-SBJ-1
      (NP (NN:[511..521] Proteasome) (NN:[522..532] inhibition))
      (PP (IN:[533..535] by)
        (NP (NN:[536..540] drug) (NN:[541..547] action))))
    (VP (VBZ:[548..551] has)
      (ADVP-TMP (RB:[553..563] previously))
      (VP (VBN:[564..568] been)
        (VP (VBN:[569..574] shown)
          (S
            (NP-SBJ-1 (-NONE-:[574..574] *))
            (VP (TO:[575..577] to)
              (VP
                (VP (VB:[578..584] induce)
                  (NP (DT:[585..586] a)
                    (ADJP (NN:[587..591] heat) (HYPH:[591..592] -)
                          (NN:[592..597] shock))
                    (NN:[598..606] response)))
                (CC:[607..610] and)
                (VP (VB:[611..617] render)
                  (NP
                    (NP (NN:[618..628] protection))
                    (PP (IN:[630..637] against)
                      (NP (NN:[638..644] stress)))))))))))
    (.:[644..645] .)))

;sentence 7 Span:646..759
;We investigated UBB+1 by developing a stable, conditional  expression model
;in SH-SY5Y human neuroblastoma cells.
;[662..667]:gene-protein:"UBB+1"
;[739..752]:malignancy-type:"neuroblastoma"
(SENT
  (S
    (NP-SBJ (PRP:[646..648] We))
    (VP (VBD:[649..661] investigated)
      (NP (NN:[662..667] UBB+1))
      (PP-MNR (IN:[668..670] by)
        (S-NOM
          (NP-SBJ (-NONE-:[670..670] *))
          (VP (VBG:[671..681] developing)
            (NP (DT:[682..683] a) (JJ:[684..690] stable) (,:[690..691] ,)
                (JJ:[692..703] conditional) (NN:[705..715] expression)
                (NN:[716..721] model))
            (PP (IN:[722..724] in)
              (NP (NN:[725..732] SH-SY5Y) (JJ:[733..738] human)
                  (NN:[739..752] neuroblastoma) (NNS:[753..758] cells)))))))
    (.:[758..759] .)))

;sentence 8 Span:760..993
;Induction of UBB+1  expression caused proteasome inhibition as was confirmed
;by reduced ability to  process misfolded canavanyl proteins, accumulation of
;GFPu, a proteasome  substrate, and reduced cleavage of a fluorogenic
;substrate.
;[773..778]:gene-protein:"UBB+1"
;[798..808]:gene-protein:"proteasome"
;[878..896]:gene-protein:"canavanyl proteins"
;[914..918]:gene-protein:"GFPu"
;[922..932]:gene-protein:"proteasome"
(SENT
  (S
    (NP-SBJ
      (NP (NN:[760..769] Induction))
      (PP (IN:[770..772] of)
        (NP (NN:[773..778] UBB+1) (NN:[780..790] expression))))
    (VP (VBD:[791..797] caused)
      (NP (NN:[798..808] proteasome) (NN:[809..819] inhibition))
      (SBAR (IN:[820..822] as)
        (S
          (NP-SBJ-1 (-NONE-:[822..822] *))
          (VP (VBD:[823..826] was)
            (VP (VBN:[827..836] confirmed)
              (NP-1 (-NONE-:[836..836] *))
              (PP (IN:[837..839] by)
                (NP
                  (NP (VBN:[840..847] reduced) (NN:[848..855] ability)
                    (S
                      (NP-SBJ (-NONE-:[855..855] *))
                      (VP (TO:[856..858] to)
                        (VP (VB:[860..867] process)
                          (NP (VBN:[868..877] misfolded)
                             (NN:[878..887] canavanyl) (NNS:[888..896] proteins))))))
                  (,:[896..897] ,)
                  (NP
                    (NP (NN:[898..910] accumulation))
                    (PP (IN:[911..913] of)
                      (NP
                        (NP (NN:[914..918] GFPu))
                        (,:[918..919] ,)
                        (NP (DT:[920..921] a) (NN:[922..932] proteasome)
                            (NN:[934..943] substrate)))))
                  (,:[943..944] ,) (CC:[945..948] and)
                  (NP
                    (NP (VBN:[949..956] reduced) (NN:[957..965] cleavage))
                    (PP (IN:[966..968] of)
                      (NP (DT:[969..970] a) (JJ:[971..982] fluorogenic)
                          (NN:[983..992] substrate)))))))))))
    (.:[992..993] .)))

;sentence 9 Span:994..1070
;We show that  expression of UBB+1 induces expression of heat-shock proteins.
;[1022..1027]:gene-protein:"UBB+1"
;[1050..1069]:gene-protein:"heat-shock proteins"
(SENT
  (S
    (NP-SBJ (PRP:[994..996] We))
    (VP (VBP:[997..1001] show)
      (SBAR (IN:[1002..1006] that)
        (S
          (NP-SBJ
            (NP (NN:[1008..1018] expression))
            (PP (IN:[1019..1021] of)
              (NP (NN:[1022..1027] UBB+1))))
          (VP (VBZ:[1028..1035] induces)
            (NP
              (NP (NN:[1036..1046] expression))
              (PP (IN:[1047..1049] of)
                (NP
                  (NML (NN:[1050..1054] heat) (HYPH:[1054..1055] -)
                       (NN:[1055..1060] shock))
                  (NNS:[1061..1069] proteins))))))))
    (.:[1069..1070] .)))

;sentence 10 Span:1071..1212
;This priming of  the chaperone system in these cells promotes a subsequent
;resistance to  tert-butyl hydroperoxide-mediated oxidative stress.
;[1092..1101]:gene-protein:"chaperone"
(SENT
  (S
    (NP-SBJ
      (NP (DT:[1071..1075] This) (NN:[1076..1083] priming))
      (PP (IN:[1084..1086] of)
        (NP (DT:[1088..1091] the) (NN:[1092..1101] chaperone)
            (NN:[1102..1108] system)))
      (PP (IN:[1109..1111] in)
        (NP (DT:[1112..1117] these) (NNS:[1118..1123] cells))))
    (VP (VBZ:[1124..1132] promotes)
      (NP
        (NP (DT:[1133..1134] a) (JJ:[1135..1145] subsequent)
            (NN:[1146..1156] resistance))
        (PP (TO:[1157..1159] to)
          (NP
            (ADJP
              (NML (NN:[1161..1171] tert-butyl) (NN:[1172..1185] hydroperoxide))
              (HYPH:[1185..1186] -) (VBN:[1186..1194] mediated))
            (JJ:[1195..1204] oxidative) (NN:[1205..1211] stress)))))
    (.:[1211..1212] .)))

;sentence 11 Span:1213..1367
;We conclude that although  UBB+1-expressing cells have a compromised
;ubiquitin-proteasome system, they are  protected against oxidative stress
;conditions.
;[1240..1246]:gene-protein:"UBB+1-"
;[1282..1291]:gene-protein:"ubiquitin"
;[1292..1302]:gene-protein:"proteasome"
(SENT
  (S
    (NP-SBJ (PRP:[1213..1215] We))
    (VP (VBP:[1216..1224] conclude)
      (SBAR (IN:[1225..1229] that)
        (S
          (SBAR-ADV (IN:[1230..1238] although)
            (S
              (NP-SBJ
                (ADJP
                   (NN:[1240..1245] UBB+1) (HYPH:[1245..1246] -)
                  (VBG:[1246..1256] expressing))
                (NNS:[1257..1262] cells))
              (VP (VBP:[1263..1267] have)
                (NP (DT:[1268..1269] a) (VBN:[1270..1281] compromised)
                  (NML (NN:[1282..1291] ubiquitin) (HYPH:[1291..1292] -)
                       (NN:[1292..1302] proteasome))
                  (NN:[1303..1309] system)))))
          (,:[1309..1310] ,)
          (NP-SBJ-1 (PRP:[1311..1315] they))
          (VP (VBP:[1316..1319] are)
            (VP (VBN:[1321..1330] protected)
              (NP-1 (-NONE-:[1330..1330] *))
              (PP (IN:[1331..1338] against)
                (NP (JJ:[1339..1348] oxidative) (NN:[1349..1355] stress)
                    (NNS:[1356..1366] conditions))))))))
    (.:[1366..1367] .)))

;section 12 Span:1371..1416
;PMID: 12871580 [PubMed - indexed for MEDLINE]
(SEC
  (FRAG (NNP:[1371..1375] PMID) (::[1375..1376] :) (CD:[1377..1385] 12871580)
        (NN:[1386..1387] -LSB-) (NNP:[1387..1393] PubMed) (::[1394..1395] -)
        (NN:[1396..1403] indexed) (IN:[1404..1407] for)
        (NNP:[1408..1416] MEDLINE-RSB-)))
